Fundraising Fox
/Companies
Sign in

NMD Pharma

Aarhus, DK · Founded 2015 · 85 employees on LinkedIn · 8 known investors

Find your way into NMD Pharma

Sign up to see every warm intro you have to NMD Pharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NMD Pharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions. Its lead candidate, ignaseclant (NMD670), is in clinical development for Charcot-Marie-Tooth disease, generalized myasthenia gravis, and spinal muscular atrophy.</parameter> <parameter name="founders">[]

BiotechDeep TechHealthtechMedical Devices

Investors · 8

Novo Holdings✓ confirmed by NMD PharmaCopenhagen · $1.1M – $54M

How we know: the company's own site · funding news · globenewswire.com · Not right? Tell us

Inkeflisted by InkefAmsterdam

How we know: Inkef's portfolio page · funding news · globenewswire.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Roche Venture Fundlisted by Roche Venture FundBasel · $648K – $3.2M

How we know: Roche Venture Fund's portfolio page · funding news · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us

Lundbeckfonden VenturesreportedKøbenhavn

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

SynconareportedLondon

How we know: a partner's Signal profile · Not right? Tell us

Also in the syndicate · 2

Lundbeckfonden BioCapitalthe Roche Venture Fund

Funding

SEC filings, press & company announcements

$80M disclosed across 1 round · 2023

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 2

UclahealthUCLA Health is a major academic health system providing patient care across five hospitals and 290 clinics in Southern California and the Central Coast, alongside research and medical education. The organization conducts pioneering research in oncology, transplantation, neurosurgery, and other specialties, having contributed to the development of numerous FDA-approved treatments.
OsmosisOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.

Companies working in the same space as NMD Pharma.

In the news

NMD Pharma Raises €75 Million (~$80 million) in a Series B Financingglobenewswire.com · Nov 2023

Frequently asked questions

What does NMD Pharma do?
NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions. Its lead candidate, ignaseclant (NMD670), is in clinical development for Charcot-Marie-Tooth disease, generalized myasthenia gravis, and spinal muscular atrophy.</parameter> <parameter name="founders">[]
Who are NMD Pharma's investors?
NMD Pharma's investors include Jeito Capital, Novo Holdings, Inkef, Roche Venture Fund, Lundbeckfonden Ventures, Syncona.
How much funding has NMD Pharma raised?
NMD Pharma has disclosed $80M raised across 1 round.
Where is NMD Pharma headquartered?
NMD Pharma is headquartered in Aarhus, DK.